continu subcutan octreotid infus dose-respons relationship metabol effect octreotid clearanc patient insulin-depend type diabet octreotid sandostatin potent long-act octapeptid analogu somatostatin variabl metabol effect type diabet interindividu variabl octreotid metabol respons part differ metabol respons previou clinic studi end plasma level mcr octreotid continu SC infus low dose microgram high dose microgram femal peptide-neg patient type diabet metabol effect analogu serum glucos free insulin glucagon GH PP level interv dose analogu control salin solut infus single-blind random manner mean daytim hour bedtim hour glucos level analogu therapi control mean free insulin level octreotid infus control similar daili insulin requir dose analogu GH glucagon PP steady-st octreotid level patient low mean sem rang pg/ml high mean rang pg/ml mean mcr valu similar dose interindividu variabl low mean rang ml/kg/min high mean rang ml/kg/min 